Work

Phase I study of mesothelin-targeted immunotoxin LMB-100 given as a long infusion with or without nab-paclitaxel.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.3553

Authors: Guillaume Joe Pegna, Mehwish Iqra Ahmad, Yunkai Yu, Akira Yuno, Min-Jung Lee, Cody J. Peer, Seth M. Steinberg, Liang Cao, Jane B Trepel, William Douglas Figg, Raffit Hassan, Ira Pastan, Christine Campo Alewine

Institutions: National Cancer Institute, Center for Cancer Research, National Institutes of Health

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3031612159

Cites:

Cited by: 2

Related to: 10